SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

“There is no better solution for Zim than the one we created”

Software developers face rising unemployment as Israel’s tech sector evolves

Marvell and Tower hit 5 million chip milestone in AI networking push

Apple agrees to build chips with Intel in the U.S., Trump says

Buzz

Most popular

Daily

Weekly

1

Jewish family from Mexico donates NIS 200 million to establish Israel's largest rehabilitation hospital

2

After raising $20 million, collapsed startup Swish.ai sells to Unframe for just $150,000

3

Echo: “Employees have become very good at identifying performative culture”

4

After PTSD and years of insomnia, Israeli founder raises $6.5 million to improve sleep through scent

5

More than 50 years after its debut, Israel's Kfir fighter jet gets a new lease on life

Protai

2 stories about Protai

Protai Founders

Protai adds $12 million to Seed round as it aims to build oncology drug discovery pipeline

The Israeli startup, which has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level, aims to better predict which patients will respond to a given drug as well as discover novel drug targets that were missed by genomic approaches

Kirill Pevzner and Eran Seger Protai

Protai raises $8 million in Seed for its proteomics-based platform for drug discovery

05.01.22|James Spiro

The company has developed an end-to-end AI-based platform that can map the course of a disease on the protein level